Work

Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19

Year: 2020

Type: editorial

Abstract: Coronavirus disease-19 (COVID-19) is a new disease caused by SARS-CoV-2. Since the beginning of 2020, it has become one of the main challenges of our times, causing a high incidence of severe pneumonia, acute respiratory distress syndrome (ARDS), multiorgan failure, and death. 1 At the root of COVID-19 lies the sudden development of "cytokine storms," hyperinflammatory responses involving the release of pro-inflammatory cytokines (eg, TNF, IL-6, IL-1, IL-8, and

Source: Allergy

DOI: 10.1111/all.14595

Authors: Evangelos Andreakos, Maria Papadaki, Charles N. Serhan

Institutions: Biomedical Research Foundation of the Academy of Athens, Imperial College London, Brigham and Women's Hospital, Harvard University

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze